Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 90
Filtrer
1.
J Obstet Gynaecol ; 42(8): 3701-3705, 2022 Nov.
Article de Anglais | MEDLINE | ID: mdl-36571208

RÉSUMÉ

The aim of this study was to explore provider practices and attitudes towards routine follow-up counselling after prescription of contraceptives. An anonymous 16-item survey was pilot-tested and sent to providers of the Internal Medicine, Family Medicine, Pediatrics, and OBGYN departments of Thomas Jefferson University Hospitals (TJUH), an urban academic medical centre in Philadelphia, PA, USA. Frequency and descriptive statistics were used to analyse quantitative data while a framework analysis approach was applied to open-ended questions. Fifty percent of providers said they typically follow up with patients regarding a newly prescribed contraceptive. Only 15.3% said they do for an existing prescription. Eighty-three percent reported that it is important though only 30% believed follow-up guidelines were clear. Ultimately, there is a gap between providers' interest in delivering follow-up care and established direction on how to do so.Impact StatementWhat is already known on the subject? Prescription contraceptive adherence is suboptimal. However, it is known that proactive follow-up has positive effects on prescription contraceptive adherence.What do the results of the study add? Most respondents believe that patients take their prescription contraception as prescribed. In light of this finding, providers are less likely to follow up with an existing prescription contraceptive. Interestingly, most respondents do believe that follow-up is important for patients using prescribed contraception but endorse that guidelines about follow-up are neither established nor clear.What are the implications of these findings for clinical practice and/or further research? Patient adherence to prescription contraceptives can be improved through optimised routine patient follow-up after initial prescription. This must be done in ways that minimise burdens to both patients and providers. Providers could benefit from clear guidelines regarding best practices. Future research is needed to understand how providers can best support patients on their contraceptive journey.


Sujet(s)
Attitude du personnel soignant , Continuité des soins , Contraception , Ordonnances , Enfant , Femelle , Humains , Attitude , Contraception/méthodes , Contraceptifs oraux , Connaissances, attitudes et pratiques en santé
2.
Phys Chem Chem Phys ; 16(42): 23044-55, 2014 Nov 14.
Article de Anglais | MEDLINE | ID: mdl-25247609

RÉSUMÉ

Two homopolyimides and the corresponding block copolyimide, all based on the 4,4'-(hexafluoroisopropylidene)diphthalic dianhydride (6FDA), have been synthesized and fully atomistic models have been studied using molecular dynamics (MD) simulation. The respective diamines were 1,3-phenylenediamine (mPDA) and 2,3,5,6-tetramethyl-1,4-phenylenediamine (durene). These polyimides are potential candidates for gas separation applications. The synthesized polymers were processed as dense flat membranes. The effects of diamine structure were investigated at the molecular level and an attempt to compare the structural features of homo- and block copolyimides was made. Amorphous models were generated using a hybrid pivot Monte Carlo-MD sampling preparation technique. Average model densities were validated against experimental measurements on the dense films. Cohesive energies, Hildebrand solubility parameters, conformational characteristics, intermolecular interactions and available void spaces were analysed for each system. The durene diamine was found to hinder stacking and increase the available space. This is associated with the steric effect of the methyl substituents. In general, 6FDA-mPDA/durene exhibits an intermediate behaviour with respect to its base polyimides. For most of the examined properties, the differences between different size simulated systems were minor with the exception of the free volume distribution.

3.
BJOG ; 120(9): 1116-22, 2013 Aug.
Article de Anglais | MEDLINE | ID: mdl-23651010

RÉSUMÉ

OBJECTIVE: To assess the relationship between unintended pregnancy and postpartum depression. DESIGN: Secondary analysis of data from a prospective pregnancy cohort. SETTING: The study was performed at the University of North Carolina prenatal care clinics. POPULATION/SAMPLE: Pregnant women enrolled for prenatal care at the University of North Carolina Hospital Center. METHODS: Participants were questioned about pregnancy intention at 15-19 weeks of gestation, and classified as having an intended, mistimed or unwanted pregnancy. They were evaluated for postpartum depression at 3 and 12 months postpartum. Log binomial regression was used to assess the relationship between unintended pregnancy and depression, controlling for confounding by demographic factors and reproductive history. MAIN OUTCOME MEASURES: Depression at 3 and 12 months postpartum, defined as Edinburgh Postpartum Depression Scale score >13. RESULTS: Data were analysed for 688 women at 3 months and 550 women at 12 months. Depression was more likely in women with unintended pregnancies at both 3 months (risk ratio [RR] 2.1, 95% confidence interval [95% CI] 1.2-3.6) and 12 months (RR 3.6, 95% CI 1.8-7.1). Using multivariable analysis adjusting for confounding by age, poverty and education level, women with unintended pregnancies were twice as likely to have postpartum depression at 12 months (RR 2.0, 95% CI 0.96-4.0). CONCLUSION: While many elements may contribute to postpartum depression, unintended pregnancy could also be a contributing factor. Women with unintended pregnancy may have an increased risk of depression up to 1 year postpartum.


Sujet(s)
Dépression du postpartum/diagnostic , Grossesse non planifiée/psychologie , Grossesse non désirée/psychologie , Adulte , Dépression du postpartum/épidémiologie , Femelle , Humains , Modèles logistiques , Caroline du Nord/épidémiologie , Grossesse , Prise en charge prénatale , Études prospectives , Appréciation des risques , Facteurs de risque , Facteurs socioéconomiques , Enquêtes et questionnaires , Facteurs temps
4.
Br J Anaesth ; 111(2): 249-55, 2013 Aug.
Article de Anglais | MEDLINE | ID: mdl-23568851

RÉSUMÉ

BACKGROUND: Activation of nicotinic receptors with nicotine has been shown to reduce post-surgical pain in clinical and preclinical studies. Choline is a selective agonist at α7-type nicotinic receptors that does not have addictive or sympathetic activating properties. It is anti-nociceptive in animal studies. We conducted a double-blind randomized trial of oral choline supplementation with lecithin to aid in the treatment of pain after gynaecological surgery. METHODS: Sixty women having open gynaecological surgery were randomly assigned to receive 20 g of lecithin before surgery or placebo. Plasma choline concentration and tumour necrosis factor (TNF) were measured. Pain report was the primary outcome measure. RESULTS: We achieved a small but statistically significant increase in choline after surgery with oral supplementation. Plasma TNF was not decreased and pain report was not different between groups at rest or with movement. There were no adverse effects of treatment. CONCLUSIONS: Oral supplementation with lecithin during the perioperative period resulted in very slow absorption and thus only a small increase in plasma choline was achieved. This concentration was inadequate to reduce TNF as has been shown in other studies. The absence of an anti-inflammatory effect was likely related to our failure to demonstrate efficacy in pain reduction.


Sujet(s)
Choline/usage thérapeutique , Compléments alimentaires , Procédures de chirurgie gynécologique , Lipotropes/usage thérapeutique , Douleur postopératoire/traitement médicamenteux , Administration par voie orale , Adolescent , Adulte , Choline/sang , Méthode en double aveugle , Femelle , Humains , Lécithines/administration et posologie , Lipotropes/sang , Adulte d'âge moyen , Mesure de la douleur/méthodes , Projets pilotes , Facteur de nécrose tumorale alpha/sang , Facteur de nécrose tumorale alpha/effets des médicaments et des substances chimiques , Jeune adulte
5.
Clin Toxicol (Phila) ; 51(2): 96-105, 2013 Feb.
Article de Anglais | MEDLINE | ID: mdl-23331216

RÉSUMÉ

CONTEXT: Over two million poisoning exposures are reported to U.S. poison control centers annually. A broad population-based survey of toxic exposures and the correlated patterns of reported kidney injury (acute or chronic) have not been systematically characterized. OBJECTIVE: Our objective was to study the demographic and exposure patterns associated with indicators for serious kidney complications (ISKC), as defined by the variables in the NPDS. MATERIALS AND METHODS: This was a retrospective, case-control study using the data elements available in the NPDS. We assessed data related to patient characteristics, substance exposure, and management. Cases and controls were derived from adult and pediatric exposures documented in NPDS (2001-2007) as having "renal effects." For substance-specific analyses, cases were restricted to those involving single substances or single entity pharmaceutical preparations. ISKC cases presented with one or more of the following NPDS codes: increased creatinine, and/or oliguria/anuria, and/or renal failure. Controls were subjects with "renal effects" but did not have increased creatinine, nor anuria/oliguria, nor renal failure. Univariate and multivariate logistic regression analyses identified factors associated with ISKC and determined the relationship between these factors. RESULTS: From the approximate 16.8 million exposures reported to the NPDS within the study timeframe, there were 16,444 single substance exposures with renal effects of which 9,074 cases experienced ISKC (55.2%) compared to 7,370 controls without ISKC. Cases with ISKC tended to be males, adults, and reported to involve intentional exposures. Cases with ISKC had higher rates of reported hemodialysis/hemofiltration (27.7%; N = 2,517) and death (10.9%; N = 990) compared to controls, respectively, (2.1%; N = 155) and (0.8%; N = 60), p < 0.001. Substances considered a priori to be nephrotoxic were associated with a higher risk of ISKC. DISCUSSION AND CONCLUSION: The NPDS provided insight into the subjects and types of exposures that associate with ISKC. Subjects with ISKC experienced higher rates of morbidity and mortality compared to subjects without ISKC. We identified subject characteristics and classes of compounds associated with ISKC. We hope that the hypotheses generated from this study of the NPDS will raise awareness of the possible risk factors and complications associated with ISKC.


Sujet(s)
Maladies du rein/induit chimiquement , Maladies du rein/épidémiologie , Intoxication/complications , Intoxication/épidémiologie , Atteinte rénale aigüe/induit chimiquement , Adolescent , Adulte , Facteurs âges , Sujet âgé , Anurie/étiologie , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Soins de réanimation , Bases de données factuelles , Femelle , Produits domestiques/intoxication , Humains , Nourrisson , Maladies du rein/mortalité , Tests de la fonction rénale , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Nouveau Mexique/épidémiologie , Odds ratio , Intoxication/mortalité , Études rétrospectives , Facteurs sexuels , Tentative de suicide , États-Unis/épidémiologie , Jeune adulte
6.
Cytogenet Genome Res ; 129(1-3): 143-53, 2010 Jul.
Article de Anglais | MEDLINE | ID: mdl-20628250

RÉSUMÉ

Plant meiosis studies have enjoyed a fantastic boom in recent years with the use of Arabidopsis thaliana as a model not only for molecular genetics and genomics but also for cytogenetics. In this article we describe a new protocol for immunolabelling meiotic proteins that allows the detection of a large range of proteins on strongly spread chromosomes throughout the entire meiotic process. We used this method to immunodetect MLH1, a crucial component of the meiotic recombination machinery, and found that it can be visualised as foci from pachytene to diakinesis, where it co-localises with chiasmata. The mean MLH1 foci number per meiotic cell at diakinesis was 8.4 for WS-4 and 9.95 for Col-0, with the number of foci per bivalent ranging from 1 to 5. We also analysed MLH1 distribution within bivalents and found that they were not restricted to specific chromosomal regions. The analysis of MLH1 foci formation in the Atzip4 mutant, where class I crossover (CO) formation is prevented, revealed that residual chiasmata were not labelled by MLH1, strongly suggesting that MLH1 antibodies only label class I COs in Arabidopsis. It thus appears that the 'obligatory CO' is systematically labeled by MLH1 and is generated through the class I pathway.


Sujet(s)
Protéines d'Arabidopsis/métabolisme , Arabidopsis/cytologie , Arabidopsis/génétique , Analyse cytogénétique/méthodes , Immunohistochimie/méthodes , Méiose/génétique , Adenosine triphosphatases/immunologie , Adenosine triphosphatases/métabolisme , Animaux , Anticorps , Arabidopsis/métabolisme , Protéines d'Arabidopsis/immunologie , Protéines du cycle cellulaire/métabolisme , Chromatine/génétique , Chromatine/métabolisme , Protéines chromosomiques nonhistones/métabolisme , Chromosomes de plante/génétique , Chromosomes de plante/métabolisme , Crossing-over , Histone/métabolisme , Méiose/physiologie , Protéine-1 homologue de MutL , Rats , Recombinaison génétique ,
7.
Rev Sci Instrum ; 80(11): 113102, 2009 Nov.
Article de Anglais | MEDLINE | ID: mdl-19947712

RÉSUMÉ

We report on an innovative two-dimensional imaging extreme ultraviolet (XUV) interferometer operating at 32 nm based on the mutual coherence of two laser high order harmonics (HOH) sources, separately generated in gas. We give the first evidence that the two mutually coherent HOH sources can be produced in two independent spatially separated gas jets, allowing for probing centimeter-sized objects. A magnification factor of 10 leads to a micron resolution associated with a subpicosecond temporal resolution. Single shot interferograms with a fringe visibility better than 30% are routinely produced. As a test of the XUV interferometer, we measure a maximum electronic density of 3x10(20) cm(-3) 1.1 ns after the creation of a plasma on aluminum target.

8.
Genome Dyn ; 5: 14-25, 2009.
Article de Anglais | MEDLINE | ID: mdl-18948704

RÉSUMÉ

Efforts have been made in recent years to clarify molecular meiotic processes in a large variety of higher eukaryotes. In plants, such studies have enjoyed a boom in the last years with the use of Arabidopsis thaliana together with maize, rice and tomato as model systems. Owing to direct and reverse genetic screens, an increasing number of genes involved in meiosis have been characterized in plants. In parallel, the improvement of cytological and genetical tools has allowed a precise description of meiotic recombination events. Thus, it appears that meiotic studies in plants are reaching a new stage and can provide new insights into meiotic recombination mechanisms. In this review, we intend to give an overview of these recent advances in the understanding of meiotic recombination in plants.


Sujet(s)
Crossing-over , Méiose , Cellules végétales , Plantes/génétique , Recombinaison génétique , Marqueurs génétiques , Modèles génétiques
9.
Cytogenet Genome Res ; 120(3-4): 281-90, 2008.
Article de Anglais | MEDLINE | ID: mdl-18504357

RÉSUMÉ

Plants have always been at the forefront of genetic and cytogenetic studies, but it was only following the explosion of genomic tools linked to the development of Arabidopsis thaliana as a model, that the first genes involved in plant meiosis were cloned in the late 1990s. Since then, in less than 10 years, close to fifty plant meiotic genes have been functionally characterized, mainly in Arabidopsis but also in rice and maize. In this review, we give an overview of this decade of discovery, with emphasis on the strategies that have been used for meiotic gene identification. We also highlight particularly interesting breakthroughs that these mutant and gene screens made possible.


Sujet(s)
Gènes de plante , Méiose/génétique , Cellules végétales , Plantes/génétique , Arabidopsis/cytologie , Arabidopsis/génétique , Arabidopsis/métabolisme , Protéines du cycle cellulaire/génétique , Protéines du cycle cellulaire/métabolisme , Protéines chromosomiques nonhistones/génétique , Protéines chromosomiques nonhistones/métabolisme , Cytogénétique , Cassures double-brin de l'ADN , ADN des plantes/génétique , Kinétochores/métabolisme , Mutation , Protéines nucléaires/génétique , Protéines nucléaires/métabolisme , Protéines végétales/génétique , Protéines végétales/métabolisme , Plantes/métabolisme , Recombinaison génétique , Complexe synaptonémal/génétique ,
10.
Genetics ; 176(3): 1453-67, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17483430

RÉSUMÉ

Crossover interference in meiosis is often modeled via stationary renewal processes. Here we consider a new model to incorporate the known biological feature of "obligate chiasma" whereby in most organisms each bivalent almost always has at least one crossover. The initial crossover is modeled as uniformly distributed along the chromosome, and starting from its position, subsequent crossovers are placed with forward and backward stationary renewal processes using a chi-square distribution of intercrossover distances. We used our model as well as the standard chi-square model to simulate the patterns of crossover densities along bivalents or chromatids for those having zero, one, two, or three or more crossovers; indeed, such patterns depend on the number of crossovers. With both models, simulated patterns compare very well to those found experimentally in mice, both for MLH1 foci on bivalents and for crossovers on genetic maps. However, our model provides a better fit to experimental data as compared to the standard chi-square model, particularly regarding the distribution of numbers of crossovers per chromosome. Finally, our model predicts an enhancement of the recombination rate near the extremities, which, however, explains only a part of the pattern observed in mouse.


Sujet(s)
Chromosomes de mammifère , Modèles génétiques , Recombinaison génétique , Protéines adaptatrices de la transduction du signal , Animaux , Loi du khi-deux , Chromatides , Cinétique , Souris , Protéine-1 homologue de MutL , Protéines nucléaires
11.
J Pept Res ; 66(3): 138-50, 2005 Sep.
Article de Anglais | MEDLINE | ID: mdl-16083441

RÉSUMÉ

The cannabinoid receptor 1 (CB1) cannabinoid receptor is an essential component of the cannabinergic system. It has been recognized as a therapeutic target for treating numerous diseases and is currently receiving considerable attention by the pharmaceutical community. Target-based drug design, utilizing three-dimensional information of receptor structure and ligand-binding motifs, requires significant amounts of purified protein. To facilitate the purification of CB1, we have expressed the receptor fused to various epitope tags using the baculovirus expression system. In addition, expression levels and ligand-binding profiles corresponding to the expressed fusion proteins have been compared. C-terminal histidine (His)-tagged CB1 gave a Bmax higher than most other systems previously reported in the literature, and was selected for subsequent metal affinity chromatography purification and mass spectroscopic (MS) analysis. Moreover, cells expressing C-terminal His-tagged CB1 were shown to inhibit forskolin-stimulated cyclic adenosine 3',5'-monophosphate (cAMP) production in a concentration-dependent manner in the presence of CP-55,940, confirming the expressed receptor's functional characteristics. A Western blot analysis of the purified receptor showed several forms of CB1, the most abundant being a 57 kDa monomeric protein. The purified CB1 preparations were subjected to protein digestion followed by MS. Fragments corresponding to >70% of the receptor were identified by this method, confirming the identity and purity of the expressed protein. The work presented here demonstrates that epitope-tagged CB1 can be expressed in sufficient amounts and purified to homogeneity for MS analysis. Moreover, these results will serve as a basis for future experiments aimed at characterizing the ligand-binding domains using covalently reacting receptor probes.


Sujet(s)
Spectrométrie de masse/méthodes , Récepteur cannabinoïde de type CB1/isolement et purification , Séquence d'acides aminés , Animaux , Baculoviridae/génétique , Séquence nucléotidique , Clonage moléculaire , Humains , Modèles biologiques , Données de séquences moléculaires , Plasmides , Récepteur cannabinoïde de type CB1/composition chimique , Récepteur cannabinoïde de type CB1/métabolisme , Protéines recombinantes/composition chimique , Protéines recombinantes/isolement et purification
12.
Cytogenet Genome Res ; 109(1-3): 181-9, 2005.
Article de Anglais | MEDLINE | ID: mdl-15753575

RÉSUMÉ

The analysis of meiosis in higher plants has benefited considerably in recent years from the completion of the genome sequence of the model plant Arabidopsis thaliana and the development of cytological techniques for this species. A combination of forward and reverse genetics has provided important routes toward the identification of meiotic genes in Arabidopsis. Nevertheless identification of certain meiotic genes remains a challenge due to problems such as limited sequence conservation between species, existence of closely related gene families and in some cases functional redundancy between gene family members. Hence there is a requirement to develop new experimental approaches that can be used in conjunction with existing methods to enable a greater range of plant meiotic genes to be identified. As one potential route towards this goal we have initiated a proteomics-based approach. Unfortunately, the small size of Arabidopsis anthers makes an analysis in this species technically very difficult. Therefore we have initially focussed on Brassica oleracea which is closely related to Arabidopsis, but has the advantage of possessing significantly larger anthers. The basic strategy has been to use peptide mass-finger printing and matrix-assisted laser desorption ionization time of flight mass spectrometry to analyse proteins expressed in meiocytes during prophase I of meiosis. Initial experiments based on the analysis of proteins from staged anther tissue proved disappointing due to the low level of detection of proteins associated with meiosis. However, by extruding meiocytes in early prophase I from individual anthers prior to analysis a significant enrichment of meiotic proteins has been achieved. Analysis suggests that at least 18% of the proteins identified by this route have a putative meiotic function and that this figure could be as high as one-third of the total. Approaches to increase the enrichment of proteins involved in meiotic recombination and chromosome synapsis are also described.


Sujet(s)
Brassica/cytologie , Brassica/génétique , Protéines végétales/génétique , Plantes/génétique , Protéome , Noyau de la cellule/génétique , Noyau de la cellule/ultrastructure , Fleurs/cytologie , Fleurs/génétique , Méiose , Protéines végétales/isolement et purification
13.
J Pept Res ; 64(6): 225-36, 2004 Dec.
Article de Anglais | MEDLINE | ID: mdl-15613086

RÉSUMÉ

The cannabinergic system is present in a variety of organs and tissues that perform a wide range of essential physiologic functions making it an inherently important therapeutic target for drug discovery. In order to augment our knowledge regarding the interactions between cannabinoid receptors (CBs) and their ligands, efficient and effective tools are essential for robust expression and purification of these membrane-bound proteins. In this report, we describe a suitable method for purification of the human cannabinoid receptor 2 (CB2) to a qualitative and quantitative level sufficient for mass spectral analysis. We utilized a baculovirus expression system, incorporating several epitope tags to facilitate purification and to ameliorate the effect the tags have on CB2 expression and function. Expressed protein encoded by a carboxy (C)-terminal His-tagged CB2 construct displayed a B(max) value of 9.3 pmol/mg with a K(D) of 7.30 nM using [3(H)]CP-55(940), a standard cannabinoid radioligand, and was selected for subsequent purification experiments. Western blot analysis of purified membrane protein yielded several forms of CB2, the most abundant being a 41 kDa peptide. A second protein species was observed with an apparent molecular weight of 46 kDa representing a glycosylated form of CB2. In addition, a CB2 homodimer was also identified. The purified receptor was subjected to mass spectroscopic analysis to confirm its identity and purity. Mass spectra corresponding to the intracellular, extracellular and transmembrane domains were obtained. These experiments exemplify the importance of high-level expression systems when developing membrane-bound protein purification strategies. This work will aid in the identification of receptor-ligand binding sites, the characterization of molecular features involved in receptor activation, and the elucidation of the CB2 receptor tertiary structure.


Sujet(s)
Récepteur cannabinoïde de type CB2/isolement et purification , Séquence d'acides aminés , Animaux , Baculoviridae/génétique , Technique de Western , Clonage moléculaire , Humains , Spectrométrie de masse , Données de séquences moléculaires , Plasmides , Récepteur cannabinoïde de type CB2/composition chimique , Protéines recombinantes/composition chimique , Protéines recombinantes/isolement et purification
14.
Proc Natl Acad Sci U S A ; 101(23): 8756-61, 2004 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-15138300

RÉSUMÉ

The endogenous cannabinoid anandamide is removed from the synaptic space by a high-affinity transport system present in neurons and astrocytes, which is inhibited by N-(4-hydroxyphenyl)-arachidonamide (AM404). After internalization, anandamide is hydrolyzed by fatty-acid amide hydrolase (FAAH), an intracellular membrane-bound enzyme that also cleaves AM404. Based on kinetic evidence, it has recently been suggested that anandamide internalization may be mediated by passive diffusion driven by FAAH activity. To test this possibility, in the present study, we have investigated anandamide internalization in wild-type and FAAH-deficient (FAAH(-/-)) mice. Cortical neurons from either mouse strain internalized [(3)H]anandamide through a similar mechanism, i.e., via a rapid temperature-sensitive and saturable process, which was blocked by AM404. Moreover, systemic administration of AM404 to either wild-type or FAAH(-/-) mice enhanced the hypothermic effects of exogenous anandamide, a response that was prevented by the CB(1) cannabinoid antagonist rimonabant (SR141716A). The results indicate that anandamide internalization in mouse brain neurons is independent of FAAH activity. In further support of this conclusion, the compound N-(5Z, 8Z, 11Z, 14Z eicosatetraenyl)-4-hydroxybenzamide (AM1172) blocked [(3)H]anandamide internalization in rodent cortical neurons and human astrocytoma cells without acting as a FAAH substrate or inhibitor. AM1172 may serve as a prototype for novel anandamide transport inhibitors with increased metabolic stability.


Sujet(s)
Amidohydrolases/métabolisme , Acides arachidoniques/métabolisme , Acides arachidoniques/pharmacologie , Benzamides/pharmacologie , Modulateurs des récepteurs de cannabinoïdes/métabolisme , Amidohydrolases/déficit , Amidohydrolases/génétique , Animaux , Transport biologique actif/effets des médicaments et des substances chimiques , Lignée cellulaire , Endocannabinoïdes , Humains , Hydrolyse , Techniques in vitro , Souris , Souris de lignée C57BL , Souris knockout , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Amides gras polyinsaturés N-alkylés , Rats , Rat Wistar
15.
Opt Lett ; 28(15): 1374-6, 2003 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-12906094

RÉSUMÉ

We have built a diode-pumped Nd:glass regenerative amplifier that is able to produce energies up to 20 mJ within a 470-fs pulse duration at a 1-Hz repetition rate. We obtained this amplifier by using specific intracavity components such as a phase mirror and a birefringent filter to generate a large spatial mode and a large spectral width.

16.
J Clin Oncol ; 20(18): 3891-7, 2002 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-12228210

RÉSUMÉ

PURPOSE: This phase II pilot study determined the efficacy and safety of alemtuzumab (Campath-1H; Burroughs Wellcome, United Kingdom) in patients with chronic lymphocytic leukemia (CLL), all of whom had previously received fludarabine and other chemotherapy regimens. PATIENTS AND METHODS: Twenty-four patients were treated with intravenous alemtuzumab at six centers in the United States. The target dose of 30 mg over 2 hours, three times weekly, was administered for up to 16 weeks. Responses were evaluated by an independent panel of experts using 1996 National Cancer Institute-sponsored Working Group criteria. Safety assessments included analysis of lymphocyte subpopulations. Antimicrobial prophylaxis was not mandatory. RESULTS: Eight patients (33%) achieved a major response (all partial remissions), with a median time to response of 3.9 months (range, 1.6 to 5.3 months). The median duration of response was 15.4 months (range, 4.6 to >or= 38.0 months), the median time to disease progression was 19.6 months (range, 7.7 to >or= 42.0 months), and the median survival time was 35.8 months (range, 8.8 to >or= 47.1 months). Acute infusion-related events, mainly grades 1 and 2, were most common and most severe in the first week. Ten patients (eight nonresponders and two responders) experienced major infections on-study. Pneumocystis carinii pneumonia was reported in two patients on-study; neither had received prophylaxis. Median CD4+ and CD8+ counts decreased and then began to increase by the end of the study, with further recovery by 1-month follow-up. One of 53 samples obtained from 10 patients had a low titer of alemtuzumab antibodies. CONCLUSION: Alemtuzumab has significant activity in poor-prognosis, fludarabine-treated CLL patients. However, because of a relatively high incidence of opportunistic infections accompanying profound lymphopenia, future protocols should include mandatory prophylaxis.


Sujet(s)
Anticorps monoclonaux/usage thérapeutique , Anticorps antitumoraux/usage thérapeutique , Antinéoplasiques/usage thérapeutique , Leucémie chronique lymphocytaire à cellules B/traitement médicamenteux , Leucémie prolymphocytaire à cellules T/traitement médicamenteux , Vidarabine/usage thérapeutique , Adolescent , Alemtuzumab , Anticorps monoclonaux humanisés , Antigènes CD/métabolisme , Antimétabolites antinéoplasiques/usage thérapeutique , Antinéoplasiques/effets indésirables , DNA (cytosine-5-)-methyltransferase/antagonistes et inhibiteurs , Femelle , Humains , Leucémie chronique lymphocytaire à cellules B/anatomopathologie , Leucémie prolymphocytaire à cellules T/anatomopathologie , Mâle , Neutropénie/induit chimiquement , Infections opportunistes , Projets pilotes , Induction de rémission , Thérapie de rattrapage , Taux de survie , Thrombopénie/induit chimiquement , Échec thérapeutique , Résultat thérapeutique , Vidarabine/effets indésirables , Vidarabine/analogues et dérivés
17.
Genes Dev ; 15(14): 1859-71, 2001 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-11459834

RÉSUMÉ

We have characterized a new gene, SWI1, involved in sister chromatid cohesion during both male and female meiosis in Arabidopsis thaliana. A first allele, swi1.1, was obtained as a T-DNA tagged mutant and was described previously as abnormal exclusively in female meiosis. We have isolated a new allele, swi1.2, which is defective for both male and female meiosis. In swi1.2 male meiosis, the classical steps of prophase were not observed, especially because homologs do not synapse. Chromatid arms and centromeres lost their cohesion in a stepwise manner before metaphase I, and 20 chromatids instead of five bivalents were seen at the metaphase plate, which was followed by an aberrant segregation. In contrast, swi1.2 female meiocytes performed a mitotic-like division instead of meiosis, indicating a distinct role for SWI1 or a different effect of the loss of SWI1 function in both processes. The SWI1 gene was cloned; the putative SWI1 protein did not show strong similarity to any known protein. Plants transformed with a SWI1-GFP fusion indicated that SWI1 protein is present in meiocyte nuclei, before meiosis and at a very early stage of prophase. Thus, SWI1 appears to be a novel protein involved in chromatid cohesion establishment and in chromosome structure during meiosis, but with clear differences between male and female meiosis.


Sujet(s)
Protéines d'Arabidopsis , Arabidopsis/génétique , Chromatides/physiologie , Protéines chromosomiques nonhistones/génétique , Méiose/génétique , Allèles , Séquence d'acides aminés , Protéines du cycle cellulaire , Centromère , Chromatides/ultrastructure , Gamétogenèse , Données de séquences moléculaires , Protéines nucléaires , Protéines végétales/génétique
18.
Biochimie ; 83(11-12): 1023-8, 2001.
Article de Anglais | MEDLINE | ID: mdl-11879730

RÉSUMÉ

Our understanding of plant meiosis is rapidly increasing thanks to the model Arabidopsis thaliana. Here we present the results of a screening for meiotic mutants carried out with a library containing 30,719 T-DNA insertion lines. An average of one mutant per 1000 lines was recovered. Several phenotypic classes could be distinguished and are presented. In parallel, 39 proteins known to be involved in meiosis in non-plant organisms were chosen and a search was performed for homologue sequences in the completed Arabidopsis thaliana genome. Approximately 30% of the meiotic related sequences showed similarities with one or several Arabidopsis putative genes. The relevance of forward versus reverse genetics in order to characterize meiotic functions is discussed.


Sujet(s)
Arabidopsis/génétique , Méiose/génétique , Végétaux génétiquement modifiés/génétique , Chromatides/génétique , Banque de gènes , Dépistage génétique/méthodes , Génome végétal , Méiose/physiologie , Modèles génétiques , Mutagenèse par insertion , Mutation , Végétaux génétiquement modifiés/physiologie , Recombinaison génétique
19.
Infect Immun ; 68(8): 4699-705, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-10899875

RÉSUMÉ

Several lines of evidence indicate that platelets protect against endovascular infections such as infective endocarditis (IE). It is highly likely that a principal mechanism of this platelet host defense role is the release of platelet microbicidal proteins (PMPs) in response to agonists generated at sites of endovascular infection. We studied the ability of platelets to limit the colonization and proliferation of Staphylococcus aureus in an in vitro model of IE. Three isogenic S. aureus strains, differing in their in vitro susceptibility to thrombin-induced platelet microbicidal protein-1 (tPMP), were used: ISP479C (parental strain; highly susceptible to tPMP [tPMP(s)]); ISP479R (transposon mutant derived from ISP479; tPMP resistant [tPMP(r)]); or 757-5 (tPMP(r) transductant of the ISP479R genotype in the ISP479 parental background). Time-kill assays and in vitro IE models were used to examine the temporal relationship between thrombin-induced platelet activation and S. aureus killing. In time-kill studies, early platelet activation (30 min prior to bacterial exposure) correlated with a significant bactericidal effect against tPMP(s) ISP479C (r(2) > 0.90, P < 0.02) but not against tPMP(r) strains, ISP479R or 757-5. In the IE model, thrombin activation significantly inhibited proliferation of ISP479C within simulated vegetations compared to strains ISP479R or 757-5 (P < 0.05). The latter differences were observed despite there being no detectable differences among the three S. aureus strains in initial colonization of simulated vegetations. Collectively, these data indicate that platelets limit intravegetation proliferation of tPMP(s) but not tPMP(r) S. aureus. These findings underscore the likelihood that platelets play an important antimicrobial host defense role in preventing and/or limiting endovascular infections due to tPMP(s) pathogens.


Sujet(s)
Anti-infectieux/pharmacologie , Protéines du sang/pharmacologie , Chimiokines , Endocardite bactérienne/microbiologie , Activation plaquettaire , Infections à staphylocoques/microbiologie , Division cellulaire/effets des médicaments et des substances chimiques , Humains , Tests de sensibilité microbienne , bêta-Thromboglobuline
20.
Plant Physiol ; 121(3): 753-61, 1999 Nov.
Article de Anglais | MEDLINE | ID: mdl-10557223

RÉSUMÉ

Cyclic nucleotide-gated (cng) non-selective cation channels have been cloned from a number of animal systems. These channels are characterized by direct gating upon cAMP or cGMP binding to the intracellular portion of the channel protein, which leads to an increase in channel conductance. Animal cng channels are involved in signal transduction systems; they translate stimulus-induced changes in cytosolic cyclic nucleotide into altered cell membrane potential and/or cation flux as part of a signal cascade pathway. Putative plant homologs of animal cng channels have been identified. However, functional characterization (i.e. demonstration of cyclic-nucleotide-dependent ion currents) of a plant cng channel has not yet been accomplished. We report the cloning and first functional characterization of a plant member of this family of ion channels. The Arabidopsis cDNA AtCNGC2 encodes a polypeptide with deduced homology to the alpha-subunit of animal channels, and facilitates cyclic nucleotide-dependent cation currents upon expression in a number of heterologous systems. AtCNGC2 expression in a yeast mutant lacking a low-affinity K(+) uptake system complements growth inhibition only when lipophilic cyclic nucleotides are present in the culture medium. Voltage clamp analysis indicates that Xenopus laevis oocytes injected with AtCNGC2 cRNA demonstrate cyclic-nucleotide-dependent, inward-rectifying K(+) currents. Human embryonic kidney cells (HEK293) transfected with AtCNGC2 cDNA demonstrate increased permeability to Ca(2+) only in the presence of lipophilic cyclic nucleotides. The evidence presented here supports the functional classification of AtCNGC2 as a cyclic-nucleotide-gated cation channel, and presents the first direct evidence (to our knowledge) identifying a plant member of this ion channel family.


Sujet(s)
Arabidopsis/génétique , Arabidopsis/physiologie , Canaux ioniques/physiologie , Séquence d'acides aminés , Animaux , Membrane cellulaire/physiologie , Clonage moléculaire , AMP cyclique/métabolisme , GMP cyclique/métabolisme , Canaux cationiques contrôlés par les nucléotides cycliques , Femelle , Humains , Canaux ioniques/composition chimique , Canaux ioniques/génétique , Données de séquences moléculaires , Ovocytes/physiologie , Protéines végétales/composition chimique , Protéines végétales/génétique , Protéines végétales/physiologie , Protéines recombinantes/métabolisme , Alignement de séquences , Similitude de séquences d'acides aminés , Xenopus laevis
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...